FRAGMIN 2500 IU

Fragmin 2500IU Injection contains an active component as dalteparin. It is a medication used to prevent and treat blood clots. It is a type of anticoagulant, specifically a low molecular weight heparin (LMWH). This medication works by inhibiting the formation of blood clots, which can help reduce the risk of conditions like deep vein thrombosis (DVT) and pulmonary embolism. Deep vein thrombosis (DVT) is a blood clot that forms in a deep vein, usually in the legs. At the same time, pulmonary embolism is a serious condition that occurs when a clot travels to the lungs, potentially causing life-threatening complications.

Fragmin 2500IU Injection has a more predictable anticoagulant response than unfractionated heparin, allowing for easier dosing and monitoring. It has a longer half-life, which means less frequent dosing is required compared to other anticoagulants, leading to better patient compliance. Unlike warfarin, which requires frequent international normalized ratio (INR) level monitoring, this medication typically does not need such monitoring. This medication has a lower bleeding risk than other anticoagulants, making them safer for certain patient populations.

Individuals with a history of hypersensitivity or allergic reactions to Fragmin 2500IU Injection or other heparins should not use this medication. It is an anticoagulant that can increase the risk of bleeding. It should be used cautiously in patients with a history of bleeding disorders or active bleeding. Patients with severe kidney impairment may require dosage adjustments or alternative treatments, as this medication is primarily eliminated through the kidneys. It should be used cautiously in patients undergoing spinal or epidural anesthesia or lumbar puncture, as it may increase the risk of epidural or spinal hematomas, leading to paralysis.